InvestorsHub Logo
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Wednesday, 10/07/2020 3:43:29 PM

Wednesday, October 07, 2020 3:43:29 PM

Post# of 726
$NBIO A successful course of Phase 1 trials will, in theory, eventually allow the company to bring the drug to market where it will have little in the way of serious competition given the poor outcomes currently defining the brain cancer treatment context. https://biopharmajournal.com/2020/09/29/why-nascent-biotech-inc-otcmktsnbio-is-worth-a-close-look

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.